Ella Trembizki

Dr. Ella Trembizki

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2016 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
ETElla Trembizki
Ella Trembizki
HWHandan Wand
Handan Wand
BDBasil Donovan
Basil Donovan
MCMarcus Chen
Marcus Chen
CFChristopher K. Fairley
Christopher K. Fairley
DWDavid David Whiley
David David Whiley
Background. Antimicrobial resistance (AMR) by Neisseria gonorrhoeae is considered a serious global threat. Methods. In this nationwide study, we used MassARRAY iPLEX genotyping technology to examine the epidemiology of N. gonorrhoeae and associated AMR in the Australian population. All available N. gonorrhoeae isolates (n = 2452) received from Australian reference laboratories from January to June 2012 were included in the study. Genotypic data were combined with phenotypic AMR information to define strain types. Results. A total of 270 distinct strain types were observed. The 40 most common strain types accounted for over 80% of isolates, and the 10 most common strain types accounted for almost half of all isolates. The high male to female ratios (>94% male) suggested that at least 22 of the top 40 strain types were primarily circulating within networks of men who have sex with men (MSM). Particular strain types were also concentrated among females: two strain types accounted for 37.5% of all isolates from females. Isolates harbouring the mosaic penicillin binding protein 2 (PBP2)—considered a key mechanism for cephalosporin resistance—comprised 8.9% of all N. gonorrhoeae isolates and were primarily observed in males (95%). Conclusions. This large scale epidemiological investigation demonstrated that N. gonorrhoeae infections are dominated by relatively few strain types. The commonest strain types were concentrated in MSM in urban areas and Indigenous heterosexuals in remote areas, and we were able to confirm a resurgent epidemic in heterosexual networks in urban areas. The prevalence of mosaic PBP2 harboring N. gonorrhoeae strains highlight the ability for new N. gonorrhoeae strains to spread and become established across populations.

1 September 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
ETElla Trembizki
Ella Trembizki
RGRebecca Guy
Rebecca Guy
BDBasil Donovan
Basil Donovan
JKJohn M Kaldor
John M Kaldor
MLMonica M Lahra
Monica M Lahra
DWDavid David Whiley
David David Whiley

11 May 2021 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AAAbdulrahman K. S. Ayfan
Abdulrahman K. S. Ayfan
JMJoanne Macdonald
Joanne Macdonald
PHPatrick Harris
Patrick Harris
CHClaire Heney
Claire Heney
DPDavid Paterson
David Paterson
AIAdam Irwin
Adam Irwin

25 July 2016 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
CBCameron Buckley
Cameron Buckley
ETElla Trembizki
Ella Trembizki
BDBasil Donovan
Basil Donovan
MCMarcus Chen
Marcus Chen
KFKevin Freeman
Kevin Freeman
JSJiunn-Yih Su
Jiunn-Yih Su
The objective of this study was to develop a real-time PCR assay targeting the gonococcal porB gene (PorB-PCR) for predicting susceptibility of Neisseria gonorrhoeae to penicillin. This complements a previously described PCR assay for detecting penicillinase-producing N. gonorrhoeae (PPNG) developed by our laboratory (PPNG-PCR). The PorB-PCR assay was designed using six probes to characterize various combinations of amino acids at positions 101 and 102 of the PorB1b class protein, including the WT G101/A102 and mutant G101K/A102D, G101K/A102N and G101K/A102G sequences, as well as the PorB1a sequence. The ability of these sequences to predict penicillin susceptibility was initially assessed using 2307 N. gonorrhoeae isolates from throughout Australia for which phenotypic susceptibility data were available. The assay was then applied to N. gonorrhoeae-positive clinical specimens (n = 70). Specificity was assessed by testing commensal Neisseria strains (n = 75) and N. gonorrhoeae-negative clinical specimens (n = 171). Testing of the 2307 N. gonorrhoeae isolates using PorB-PCR to detect G101/A102 and PorB1a sequences identified a total of 78.4% (61.2% and 17.2%, respectively) of penicillin-susceptible isolates with specificities of 97.4% and 99.3% and positive predictive values of 98.8% and 98.9%, where PPNG strains were simultaneously identified and excluded. Similar performance data were obtained when the PorB-PCR assay was applied to the N. gonorrhoeae-positive clinical specimens. No false-positive results were observed for the N. gonorrhoeae-negative samples and no cross-reactions were observed with the non-gonococcal species. When used in parallel with the previously described PPNG-PCR, the PorB-PCR approach has the potential to facilitate individualized treatment of gonorrhoea using penicillin.

23 September 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
BABushra Saad M Alharbi
Bushra Saad M Alharbi
MSMaggy T Sikulu-Lord
Maggy T Sikulu-Lord
ALAnton Lord
Anton Lord
HZHosam M. Zowawi
Hosam M. Zowawi
ETElla Trembizki
Ella Trembizki
Antimicrobial Resistance (AMR) caused by Carbapenem-Resistant Enterobacteriaceae (CRE) is a global threat. Accurate identification of these bacterial species with associated AMR is critical for their management. While highly accurate methods to detect CRE are available, they are costly, timely and require expert skills, making their application infeasible in low-resource settings. Here, we investigated the potential of Near-Infrared Spectroscopy (NIRS) for a range of applications: (i) the detection and differentiation of isolates of two pathogenic Enterobacteriaceae species, Klebsiella pneumoniae and Escherichia coli, and (ii) the differentiation of carbapenem resistant and susceptible K. pneumoniae. NIRS has successfully differentiated between K. pneumoniae and E. coli isolates with a predictive accuracy of 89.04% (95% CI; 88.7–89.4%). K. pneumoniae isolates harbouring carbapenem-resistance determinants were differentiated from susceptible K. pneumoniae strains with an accuracy of 85% (95% CI; 84.2–86.1%). To our knowledge, this is the largest proof of concept demonstration for the utility and feasibility of NIRS to rapidly differentiate between K. pneumoniae and E. coli as well as carbapenem-resistant K. pneumoniae from susceptible strains.

13 April 2023 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
BABushra Saad M Alharbi
Bushra Saad M Alharbi
AJAmy V. Jennison
Amy V. Jennison
VHVicki Hicks
Vicki Hicks
DWDavid M. Whiley
David M. Whiley
ESEmma Sweeney
Emma Sweeney
ETElla Trembizki
Ella Trembizki
We investigated the potential effects of COVID-19 public health restrictions on the prevalence and distribution of Neisseria gonorrhoeae (NG) genotypes in our Queensland isolate population in the first half of the year 2020. A total of 763 NG isolates were genotyped to examine gonococcal strain distribution and prevalence for the first 6 months of 2020, with 1 January 2020 to 31 March 2020 classified as ‘pre’ COVID-19 restrictions (n = 463) and 1 April 2020 to 30 June 2020 classified as ‘post’ COVID-19 restrictions (n = 300). Genotypes most prevalent ‘pre’ restrictions remained proportionally high ‘post’ restrictions, with some significantly increasing ‘post’ restrictions. However, genotype diversity was significantly reduced ‘post’ restrictions. Overall, it seems public health restrictions (9–10 weeks) were not sufficient to affect rates of infection or reduce the prevalence of well-established genotypes in our population, potentially due to reduced access to services or health-seeking behaviours.